Scholar
IQ
Help
Try ScholarIQ free
Home
Papers
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Upload Records
Snowball Search
Search OpenAlex
About the database
ScholarIQ
answers from OpenAlex
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Paper
Citations, authors & open-access status
2,817
Citations
2,018
Year
bronze
OA Status
IDs:
DOI
PMID
OpenAlex
Related on ScholarIQ
Scott Antonia
Author
Luis Paz‐Ares
Author
Martin Reck
Author
Rina Hui
Author
Takayasu Kurata
Author
Jhanelle E. Gray
Author
470M+ articles · free account